Risk factors and characteristics associated with uncontrolled severe asthma in patients with aspirin-exacerbated respiratory disease

被引:0
|
作者
Mitsui, C. [1 ]
Taniguchi, M. [1 ]
Fukutomi, Y. [1 ]
Higashi, N. [1 ]
Ono, E. [1 ]
Kajiwara, K. [1 ]
Tanimoto, H. [1 ]
Oshikata, C. [1 ]
Sekiya, K. [1 ]
Tsuburai, T. [1 ]
Tsurikisawa, N. [1 ]
Ishii, T. [1 ]
Mori, A. [1 ]
Mita, H. [1 ]
Hasegawa, M. [1 ]
Akiyama, K. [1 ]
机构
[1] Sagamihara Natl Hosp, Dept Allergy, Sagamihara, Kanagawa, Japan
关键词
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
939
引用
收藏
页码:364 / 364
页数:1
相关论文
共 50 条
  • [41] The nose as a target organ in the diagnosis of severe aspirin-exacerbated respiratory disease
    Gonzalez-Perez, Ruperto
    Poza-Guedes, Paloma
    Vives-Conesa, Ramon
    AMERICAN JOURNAL OF RHINOLOGY & ALLERGY, 2011, 25 (03) : 166 - 169
  • [42] Which Factors Associated With Activated Eosinophils Contribute to the Pathogenesis of Aspirin-Exacerbated Respiratory Disease?
    Choi, Youngwoo
    Lee, Youngsoo
    Park, Hae-Sim
    ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2019, 11 (03) : 320 - 329
  • [43] A retrospective analysis of bronchiectasis in patients with aspirin-exacerbated respiratory disease
    Chen, Yih-Chieh S.
    Bensko, Jillian C.
    Laidlaw, Tanya M.
    Buchheit, Kathleen M.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2020, 8 (08): : 2799 - 2801
  • [44] Physiopathology and genetics in aspirin-exacerbated respiratory disease
    Pavon-Romero, Gandhi F.
    Ramirez-Jimenez, Fernando
    Alejandro Roldan-Alvarez, Marco
    Teran, Luis M.
    Falfan-Valencia, Ramces
    EXPERIMENTAL LUNG RESEARCH, 2017, 43 (08) : 327 - 335
  • [45] Upper airways in aspirin-exacerbated respiratory disease
    Choi, Jeong-Hee
    Kim, Ji-Hye
    Park, Hae-Sim
    CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 15 (01) : 21 - 26
  • [46] A Retrospective Analysis of Bronchiectasis in Patients with Aspirin-Exacerbated Respiratory Disease
    Chen, Yih-Chieh
    Bensko, Jillian
    Laidlaw, Tanya
    Buchheit, Kathleen
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 145 (02) : AB161 - AB161
  • [47] Safety of Parecoxib in Asthmatic Patients with Aspirin-Exacerbated Respiratory Disease
    Valero, Antonio
    Sanchez-Lopez, Jaime
    Bartra, Joan
    Serrano, Carlos
    Munoz-Cano, Rosa
    Roca, Jordi
    Picado, Cesar
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2011, 156 (02) : 221 - 223
  • [48] A pragmatic analysis of mepolizumab in patients with aspirin-exacerbated respiratory disease
    Tuttle, Katherine L.
    Buchheit, Kathleen M.
    Schneider, Thomas
    Blatman, Karen S. Hsu
    Barrett, Nora A.
    Laidlaw, Tanya M.
    Cahill, Katherine N.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 141 (02) : AB168 - AB168
  • [49] Effect of omalizumab on outcomes in patients with aspirin-exacerbated respiratory disease
    Jean, Tiffany
    Eng, Victoria
    Sheikh, Javed
    Kaplan, Michael S.
    Goldberg, Bruce
    Yang, Su Jau
    Samant, Shefali
    ALLERGY AND ASTHMA PROCEEDINGS, 2019, 40 (05) : 316 - 320
  • [50] Analysis of basophil activation in patients with aspirin-exacerbated respiratory disease
    Mitsui, Chihiro
    Kajiwara, Keiichi
    Ono, Emiko
    Watai, Kentaro
    Hayashi, Hiroaki
    Kamide, Yosuke
    Fukutomi, Yuma
    Sekiya, Kiyoshi
    Tsuburai, Takahiro
    Yamamoto, Kazuhiko
    Taniguchi, Masami
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 140 (04) : 1162 - +